Where Does Wall Street Think Zynerba Pharmaceuticals Inc (ZYNE) Stock Will Go?

Friday, September 29, 2023 01:31 PM | InvestorsObserver Analysts

Mentioned in this article

Where Does Wall Street Think Zynerba Pharmaceuticals Inc (ZYNE) Stock Will Go?

Wall Street is positive on Zynerba Pharmaceuticals Inc (ZYNE). On average, analysts give Zynerba Pharmaceuticals Inc a Hold rating. The average price target is $1.255, which means analysts expect the stock to decrease by -1.18% over the next twelve months. That average ranking earns Zynerba Pharmaceuticals Inc an Analyst Rating of 5, which is better than 5% of stocks based on data compiled by InvestorsObserver.

Wall Street analysts are rating ZYNE a Hold today. Find out what this means to you and get the rest of the rankings on ZYNE!

See Full ZYNE Report

Why are Analyst Ratings Important?

A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement. InvestorsObserver averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.

What's Happening With Zynerba Pharmaceuticals Inc Stock Today?

Zynerba Pharmaceuticals Inc (ZYNE) stock is trading at $1.27 as of 1:31 PM on Friday, Sep 29, a drop of -$0.01, or -0.78% from the previous closing price of $1.28. The stock has traded between $1.26 and $1.29 so far today. Volume today is less active than usual. So far 415,310 shares have traded compared to average volume of 913,388 shares. Click Here to get the full Stock Report for Zynerba Pharmaceuticals Inc stock.